AbCellera Biologics Inc. ABCL Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$43.17M-383% | -$8.95M+84.3% | -$57.12M-64.5% | -$34.73M+23.9% | -$45.62M-33.4% | ||
| $5.92M+14.2% | $5.18M+20.5% | $4.3M-4.4% | $4.5M+2.1% | $4.41M+110% | ||
| $12.01M-6.9% | $12.9M-7.1% | $13.9M-2.2% | $14.21M-3.9% | $14.79M-2.9% | ||
| -$33.52M+3.5% | -$34.74M+33.9% | -$52.59M-62.3% | -$32.4M-180% | -$11.55M-44.4% | ||
| $3.83M-61.1% | $9.84M+10.2% | $8.93M-33.2% | $13.37M+25.7% | $10.64M-32.0% | ||
| -$25.08M-133% | $75.14M+106% | $36.49M+215% | -$31.81M-501% | $7.94M-77.8% | ||
| $7.19M+74.8% | $4.12M-44.2% | $7.37M— | —— | $5.97M+44.1% | ||
| -$51.45M— | —— | -$9.28M+86.1% | -$66.83M-2,372% | $2.94M-90.1% | ||
| -$37.35M+16.2% | -$44.59M+27.5% | -$61.52M-34.4% | -$45.77M-106% | -$22.19M+6.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s cash flow data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.